2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 106.988 | 90.000 | 91.273 | 74.228 | 75.317 | 77.451 | 61.434 | 85.413 | 90.859 | 79.170 |
Total Income - EUR | 106.989 | 90.000 | 91.274 | 74.229 | 75.318 | 77.452 | 61.434 | 85.414 | 90.860 | 79.171 |
Total Expenses - EUR | 105.350 | 89.011 | 75.866 | 63.624 | 59.858 | 62.155 | 81.861 | 73.023 | 79.284 | 91.459 |
Gross Profit/Loss - EUR | 1.639 | 989 | 15.407 | 10.604 | 15.460 | 15.297 | -20.427 | 12.391 | 11.576 | -12.288 |
Net Profit/Loss - EUR | 1.374 | 831 | 14.495 | 9.339 | 14.707 | 14.522 | -21.027 | 11.554 | 10.780 | -12.961 |
Employees | 7 | 9 | 8 | 8 | 8 | 8 | 8 | 6 | 5 | 6 |
Check the financial reports for the company - Vitalmed Lab Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 26.217 | 22.319 | 18.570 | 15.630 | 12.315 | 8.924 |
Current Assets | 168.289 | 175.984 | 188.387 | 206.687 | 186.025 | 192.351 | 193.518 | 186.899 | 194.739 | 200.517 |
Inventories | 2.790 | 1.676 | 1.410 | 10.734 | 19.057 | 27.207 | 27.697 | 32.965 | 31.301 | 34.697 |
Receivables | 27.319 | 32.777 | 36.661 | 49.105 | 164.747 | 164.117 | 153.625 | 151.004 | 153.791 | 161.347 |
Cash | 138.180 | 141.531 | 150.317 | 146.847 | 2.220 | 1.027 | 12.196 | 2.930 | 9.647 | 4.473 |
Shareholders Funds | 9.707 | 10.619 | 25.005 | 33.921 | 48.005 | 61.598 | 39.404 | 50.084 | 61.019 | 75.248 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 158.582 | 165.365 | 163.382 | 172.765 | 164.236 | 153.071 | 172.684 | 152.445 | 146.035 | 134.193 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year |
8690
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Vitalmed Lab Srl